CHEMOTHERAPY
Online ISSN : 1884-5894
Print ISSN : 0009-3165
ISSN-L : 0009-3165
PHARMACOLOGICAL STUDIES ON T-1220, A NEW SEMISYNTHETIC PENICILLIN
SECOND REPORT : DISTRIBUTION, FATE AND EXCRETION
HARUE ARATANIYASUMITSU YAMANAKASHIZUKO KONOHIDEKI TATEISHI
Author information
JOURNAL FREE ACCESS

1977 Volume 25 Issue 5 Pages 783-788

Details
Abstract
Distribution, fate and excretion of T-1220, which is effective against severe infections by gram-negative bacilli, were investigated.
Rats were intravenously or intramuscularly injected T-1220 in a dose of 20 mg/kg. Biological half lives of T-1220 in rat serum were 5.72 min and 7.54 min, respectively. Biological half life of T-1220 in the injected site of muscle was 4.11 min. The levels in kidney and liver were higher than the serum level. The high level in duodenum was also observed. The total amount excreted in 24 hr urine of the rat was 22% of the injected amount. The cord blood levels were 32.46 to 76.19% of maternal serum levels in the pregnant rats. The fetal liver level was higher than other organ levels. The amniotic level was low. Approximately 30% of T-1220 was bound to serum proteins.
Content from these authors
© Japanese Society of Chemotherapy
Previous article Next article
feedback
Top